Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tinzaparin in unexplained recurrent miscarriage
2010-022715-19Phase 4Completed
- Sponsor
- University Hospital, Linköping
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of tinzaparin in recurrent miscarriage (RPL) (2 arms), sponsored by University Hospital, Linköping. Primary endpoint: Tube formation test. Started Oct 2010; status: completed.
02
Drugs
tinzaparin
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on 2010-022715-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022715-19.